Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID‑19 vaccine is used as a booster for active immunisation against SARS‑CoV‑2 virus in order to prevent COVID‑19. Pharmacology. The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector.

  3. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  4. US FDA expands GSK's RSV vaccine approval to adults ... - AOL

    www.aol.com/news/us-fda-expands-gsks-rsv...

    (Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory syncytial virus (RSV) vaccine on Friday in adults aged between 50 and 59, making it the first shot ...

  5. Respiratory syncytial virus vaccine - Wikipedia

    en.wikipedia.org/wiki/Respiratory_syncytial...

    KEGG. D12607. A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. [14] RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. [17] The RSV vaccines Arexvy ( GSK ), [3] Abrysvo ( Pfizer ), [11] and Mresvia ( Moderna) [12] are approved for ...

  6. US CDC OKs use of new Pfizer, GSK vaccines for RSV in ... - AOL

    www.aol.com/news/us-cdc-recommends-pfizer-gsk...

    The U.S. Food and Drug Administration in May approved the first of the RSV vaccines, from GSK and branded as Arexvy, and later Pfizer's Abrysvo, for people aged 60 and older. Pfizer is awaiting ...

  7. GSK Sees Strong Demand For Vaccines and Asthma Drugs ... - AOL

    www.aol.com/finance/gsk-sees-strong-demand...

    Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency ...

  8. Skycovione - Wikipedia

    en.wikipedia.org/wiki/SKYCovione

    Skycovione is a COVID-19 vaccine candidate developed by SK Bioscience and the Institute for Protein Design of the University of Washington, It is South Korea's first homegrown COVID-19 vaccine and utilizes GSK's AS03 adjuvant technology.

  9. List of GSK plc products - Wikipedia

    en.wikipedia.org/wiki/List_of_GSK_plc_products

    Fendrix (hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)) Fluarix (trivalent) & Fluarix (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) FluLaval (trivalent) & FluLaval (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) Havrix (for hepatitis A vaccine, inactivated) Hepatyrix (for hepatitis A (inactivated ...